Ahmed S. Ali, M.D., and John E. Morley, M.D.
Dr. Ali is a visiting scientist in the Division of Geriatric Medicine at Saint Louis University Health Sciences Center. Dr. Ali reports no commercial conflict of interest. During the last three years, Dr. Morley has received grant/research support from Vivus, Merck & Co., Upjohn, B. Braun McGaw, Bayer Corp and Nestec, Ltd. He has also served on the Speakers' Bureau for LXN, Organon, Ross, Pharmacia & Upjohn, Glaxo Wellcome, Hoechst Marion Roussel, Searle, Merck & Co., Roche, Bristol-Myers Squibb, Novartis, Pratt, B. Braun McGaw, Pfizer and Parke-Davis.
This activity is made possible by an unrestricted educational grant from the Novartis Foundation for Gerontology.
Release Date: 05/07/2002
Upon completion of this Cyberounds®, you should be able to:
Understand the etiology of Parkinson's Disease
Discuss the new therapeutic agents used for PD
Describe the comprehensive approach to the management of PD.